"Success fee" represents an effective strategy to promote value-based pricing, making available to patients a rapid access to innovative and expensive therapies, with an affordable impact on drug expenditure and, simultaneously, ensuring third-party payers to share with manufacturers the risk deriving from uncertain safety and effectiveness.
The efficiency of execution of public works contracts is usually defined in terms of the capacity to complete works within the costs and the time agreed on in the contract. Therefore, it has been traditionally measured considering either costs overruns or delays. Our purpose is to consider both measures simultaneously, so as to develop a measure of overall efficiency of public works contracts execution. We compute this measure, through a benchmark procedure, using a non-parametric approach (DEA -Data Envelopment Analysis). The analysis is carried out employing a detailed data set of Italian public contracts for roads and highways, in the period 2000-2005.
This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process which may lead to differences between this version and the Version of Record. Please cite this article as
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.